<DOC>
	<DOCNO>NCT02604953</DOCNO>
	<brief_summary>Wills Eye Hospital Glaucoma Research Center conduct 1-year prospective study assess ability Short Duration Transient Visual Evoked Potential ( SD- tVEP ) Steady-State Pattern electro-retinogram ( PERG ) vision test system detect visual dysfunction patient ocular hypertension . The study aim assess reversibility retinal ganglion cell ( RGC ) dysfunction administer intraocular pressure ( IOP ) lower treatment . The investigator hypothesize SD-tVEP PERG test help develop well treatment glaucoma patient increase understanding physiological relationship IOP RGC glaucomatous injury .</brief_summary>
	<brief_title>Comparing SD-tVEP PERG Tests Between Patients With Glaucoma , Patients With High Eye Pressure `` Normal '' Patients</brief_title>
	<detailed_description>Glaucoma common cause irreversible blindness worldwide . It characterize progressive loss retinal ganglion cell ( RGCs ) correspond loss vision . Elevated intraocular pressure ( IOP ) important risk factor glaucoma , role diagnosis glaucoma unclear . Although IOP-lowering therapy delay onset glaucoma patient ocular hypertension , even without therapy , 90 % patient develop glaucoma 5-year period . Visual evoked potential ( VEPs ) able detect disruption electrical signal point along visual pathway , RGCs primary visual cortex . As objective measure visual function , VEP may advantage traditional visual field test , reduce confound factor age , fatigue , mental status . There grow body evidence SD-tVEP objectively identify early visual dysfunction due glaucoma . Aim 1 : Compare result baseline SD-tVEP PERG vision test patient ocular hypertension cohort 30 healthy subject cohort 30 patient glaucoma ( vary severity ) determine ability detect visual dysfunction ocular hypertensive subject . Aim 2 : Conduct SD-tVEP PERG test system 30 patient ocular hypertension IOP reduction topical medication compare result SD-tVEP PERG treatment patient , determine ability detect reversible RGC dysfunction .</detailed_description>
	<mesh_term>Glaucoma</mesh_term>
	<criteria>Inclusion Criteria ocular hypertension patient ( Group A ) : Patients diagnose ocular hypertension per ICD9 code ocular hypertension ( 365.04 ) Age 21 80 year IOP 21 mm hg eye . Open angle Gonioscopy At least 2 normal reliable visual field ( Humphrey MD &gt; 2 Octopus MD ≤0.8 ; fixation loss , falsepositive rate , falsenegative rate &lt; 33 % ) Normal optic disk , without follow sign : rim notch , peripapillary splinter hemorrhage , C/D asymmetry &gt; 0.2 two eye BCVA ≥ 20/40 , Clear medium , Pupil diameter &gt; 3 mm symmetric Spherical refraction within + 5.0 D cylinder correction within + 3.0 D. Inclusion Criteria glaucoma patient ( Group B ) : Patients diagnose mild , moderate severe open angle glaucoma per ( 365.xx ) Age 21 80 year . Patients attend regular followup . Inclusion Criteria normal subject ( Group C ) : Individuals ocular hypertension type glaucoma . Available participate study require time frame . Age 2180 year . Incisional eye surgery within past three month . Neurological musculoskeletal problem would influence performance activity daily live . Laser therapy within previous month . Any cause visual reduction ( great 20/40 VA ) glaucoma . Any medical condition investigator 's opinion would preclude subject provide reliable valid data . History hypersensitivity Bimatoprost Brimonidine , currently take MAO inhibitor Currently take IOP lower therapy .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>glaucoma</keyword>
	<keyword>VEP</keyword>
	<keyword>PERG</keyword>
	<keyword>SD-tVEP</keyword>
	<keyword>ss-PERG</keyword>
</DOC>